Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy

Stanford University

Status: Completed

Conditions: Kidney Stone; Ureteral Calculi; Nephrolithiasis

Treatments: Device: TENS

Study type: Interventional

Funder types: Other

Identifiers

NCT05153629

IRB-62416

Details and patient eligibility

About

The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.

Enrollment: 41 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients undergoing standard of care ureteroscopy and laser lithotripsy for urinary stone disease
• Patients receiving a stent following their ureteroscopy and laser lithotripsy

Exclusion criteria

• Children
• Pregnant patients
• Patients unable to answer pain questionnaire
• Patients undergoing PCNL
• Patients being treated for Urologic malignancy with ureteroscopy
• Patients who require long term or chronic ureteral stent management
• Patient with implantable stimulators
• Patient with epilepsy
• Patients undergoing laser lithotripsy without stent placement

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

41 participants in 2 patient groups

Standard care

No Intervention group

Description:

Participants will follow standard care until the ureteral stent is removed

TENS device

Experimental group

Description:

Participants will use the TENS device until the ureteral stent is removed

Treatment:

Device: TENS